Release Date: 27/05/22 19:13 Summary: Results of Annual General Meeting Price Sensitive: No Download Document 194.8KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%